Aligos Therapeutics, Inc. SEC filings ALGS

Aligos Therapeutics, Inc. has 348 filings in SEC EDGAR's recent list, going back to Jan 16, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Aligos Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 6, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 6, 2026 Nov 6, 2026
8-K Current report
Material agreement
Sep 15, 2026 Sep 10, 2026
S-8 Employee stock plan registration Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 26, 2026 Jun 25, 2026
SCHEDULE 13D Ownership over 5% (active) Jun 24, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
DEFA14A Additional proxy material Apr 29, 2026 —
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 29, 2026 Jun 25, 2026
8-K Current report
Material agreement
Apr 21, 2026 Apr 16, 2026
8-K Current report
Other events
Apr 14, 2026 Apr 14, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
S-8 Employee stock plan registration Mar 5, 2026 —
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
3 Initial insider ownership Feb 19, 2026 Jan 29, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
8-K Current report
Officer or director change
Feb 4, 2026 Jan 29, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
S-8 Employee stock plan registration Aug 6, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
4 Insider transaction Jul 18, 2025 Jul 16, 2025
4 Insider transaction Jul 18, 2025 Jul 16, 2025
4 Insider transaction Jul 18, 2025 Jul 16, 2025
4 Insider transaction Jun 26, 2025 Jun 25, 2025
4 Insider transaction Jun 26, 2025 Jun 25, 2025
4 Insider transaction Jun 26, 2025 Jun 25, 2025
4 Insider transaction Jun 26, 2025 Jun 25, 2025
4 Insider transaction Jun 26, 2025 Jun 25, 2025
4 Insider transaction Jun 26, 2025 Jun 25, 2025
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 26, 2025 Jun 25, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
DEFA14A Additional proxy material Apr 28, 2025 —
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 28, 2025 Jun 25, 2025
PRE 14A Preliminary proxy statement Apr 16, 2025 Jun 25, 2025
EFFECT Filing Apr 3, 2025 —
424B3 Prospectus Apr 3, 2025 —
CORRESP Letter to the SEC Apr 1, 2025 —
UPLOAD Letter from the SEC Apr 1, 2025 —
S-3 Shelf registration Mar 27, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 12, 2025 —
S-8 Employee stock plan registration Mar 10, 2025 —
10-K Annual report Mar 10, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 10, 2025 Mar 10, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
D Filing Feb 28, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 12, 2025 Feb 11, 2025
8-K Current report
Officer or director change
Feb 3, 2025 Jan 30, 2025
EFFECT Filing Nov 18, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
CORRESP Letter to the SEC Nov 14, 2024 —
UPLOAD Letter from the SEC Nov 13, 2024 —
SC 13G Ownership over 5% (passive) Nov 12, 2024 —
S-8 Employee stock plan registration Nov 6, 2024 —
S-3 Shelf registration Nov 6, 2024 —
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
4 Insider transaction Oct 10, 2024 Oct 8, 2024
3 Initial insider ownership Sep 26, 2024 Sep 23, 2024
SC 13G Ownership over 5% (passive) Sep 12, 2024 —
4 Insider transaction Sep 6, 2024 Sep 4, 2024
4 Insider transaction Sep 6, 2024 Sep 4, 2024
4 Insider transaction Sep 6, 2024 Sep 4, 2024
8-K Current report
Other events
Sep 5, 2024 Sep 3, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Aug 19, 2024 Aug 14, 2024
4 Insider transaction Aug 9, 2024 Aug 7, 2024
4 Insider transaction Aug 9, 2024 Aug 7, 2024
3 Initial insider ownership Aug 9, 2024 Aug 7, 2024
3 Initial insider ownership Aug 9, 2024 Aug 7, 2024
8-K Current report
Officer or director change
Aug 8, 2024 Aug 7, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jun 28, 2024 Jun 27, 2024
4 Insider transaction Jun 28, 2024 Jun 27, 2024
4 Insider transaction Jun 28, 2024 Jun 27, 2024
4 Insider transaction Jun 28, 2024 Jun 27, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 28, 2024 Jun 27, 2024
8-K Current report
Listing notice
May 31, 2024 May 29, 2024
8-K Current report
Listing notice, Officer or director change
May 22, 2024 May 21, 2024
8-K Current report
Officer or director change
May 15, 2024 May 9, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 27, 2024
PRE 14A Preliminary proxy statement Apr 16, 2024 Jun 27, 2024
S-8 Employee stock plan registration Mar 12, 2024 —
10-K Annual report Mar 12, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 12, 2024 Mar 12, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Feb 28, 2024 Feb 27, 2024
4 Insider transaction Feb 28, 2024 Feb 27, 2024
4 Insider transaction Feb 28, 2024 Feb 27, 2024
4 Insider transaction Feb 28, 2024 Feb 27, 2024
4 Insider transaction Feb 28, 2024 Feb 27, 2024
4 Insider transaction Feb 28, 2024 Feb 27, 2024
4 Insider transaction Feb 28, 2024 Feb 27, 2024
4 Insider transaction Feb 28, 2024 Feb 27, 2024
4 Insider transaction Feb 28, 2024 Feb 27, 2024
8-K Current report
Officer or director change
Feb 28, 2024 Feb 27, 2024
SC TO-I/A Filing Feb 28, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 8, 2024 —
SC TO-I Filing Jan 30, 2024 —
SC TO-C Filing Jan 25, 2024 —
8-K Current report
Other events
Jan 25, 2024 Jan 25, 2024
424B3 Prospectus Nov 28, 2023 —
EFFECT Filing Nov 27, 2023 —
CORRESP Letter to the SEC Nov 22, 2023 —
8-K Current report
Officer or director change
Nov 22, 2023 Nov 20, 2023
UPLOAD Letter from the SEC Nov 21, 2023 —
S-3 Shelf registration Nov 17, 2023 —
8-K Current report
Officer or director change
Nov 15, 2023 Nov 9, 2023
SC 13G/A Amended ownership over 5% (passive) Nov 7, 2023 —
3 Initial insider ownership Nov 7, 2023 Oct 25, 2023
D Filing Nov 7, 2023 —
SC 13D Ownership over 5% (active) Nov 6, 2023 —
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
SC 13G Ownership over 5% (passive) Nov 2, 2023 —
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
4 Insider transaction Oct 27, 2023 Oct 25, 2023
4 Insider transaction Oct 27, 2023 Oct 25, 2023
4 Insider transaction Oct 27, 2023 Oct 25, 2023
8-K Current report
Material agreement, Unregistered share sale
Oct 25, 2023 Oct 23, 2023
8-K Current report
Other events
Oct 18, 2023 Oct 16, 2023
4 Insider transaction Sep 12, 2023 Sep 8, 2023
4 Insider transaction Sep 12, 2023 Sep 8, 2023
4 Insider transaction Sep 12, 2023 Sep 8, 2023
4 Insider transaction Sep 12, 2023 Sep 8, 2023
4 Insider transaction Sep 12, 2023 Sep 8, 2023
8-K Current report
Listing notice
Sep 7, 2023 Sep 5, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Other events
Aug 1, 2023 Jul 31, 2023
8-K Current report
Shareholder vote results
Jul 25, 2023 Jul 20, 2023
4 Insider transaction Jul 21, 2023 Jul 20, 2023
4 Insider transaction Jul 21, 2023 Jul 20, 2023
4 Insider transaction Jul 21, 2023 Jul 20, 2023
4 Insider transaction Jul 21, 2023 Jul 20, 2023
4 Insider transaction Jul 21, 2023 Jul 20, 2023
DEFR14A Filing Jun 2, 2023 —
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jul 20, 2023
4 Insider transaction Mar 17, 2023 Mar 15, 2023
4 Insider transaction Mar 17, 2023 Mar 15, 2023
4 Insider transaction Mar 17, 2023 Mar 15, 2023
4 Insider transaction Mar 17, 2023 Mar 15, 2023
4 Insider transaction Mar 17, 2023 Mar 15, 2023
4 Insider transaction Mar 17, 2023 Mar 15, 2023
S-8 Employee stock plan registration Mar 9, 2023 —
10-K Annual report Mar 9, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 9, 2023 Mar 9, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ALGS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1799448

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.